Bölüm notları
This episode explores Metech International Limited and its overall performance across Q3FY2026 and 9MFY2026. Learn how leadership is addressing serious going concern questions while executing a bold operational pivot toward environmental technology and health supplements. The discussion outlines major portfolio realignments, vital working capital support, and the key risks on the horizon.
• The complete divestment of the lab-grown diamond venture and the transfer of its operational liabilities
• Why commercial product sales paused during essential repackaging initiatives, new licensing efforts, and supplier discussions
• Groundbreaking testing of new biomass carbon reduction equipment alongside promising international agricultural nutrition partnerships
Visit BackgroundBriefing.news for SGX news, written analysis and moreFollow us on LinkedIn
Web sitesi: investorexchange.podbean.com

